ArticlePloS one2018

Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.

Antonio Rodríguez-Poncelas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.